论文部分内容阅读
目的:对胃癌新辅助化疗效果进行分析总结。方法:选取2013年9月至2014年8月武隆县人民医院收治的60例胃癌患者进行分析,分为观察组和对照组,各30例,两组患者采用不同的治疗方法进行治疗,对照组采用的治疗方法为单纯手术治疗,观察组采用的治疗方法为替吉奥胶囊联合奥沙利铂(SOX)辅助化疗新方案,经过一段时间的治疗对两组的治疗效果进行分析。结果:对照组患者治愈率63.33%明显低于观察组的86.67%,且观察组患者不良反应发生率53.33%与对照组的46.67%比较,差异均无统计学意义(P<0.05)。结论:在胃癌治疗中引入新辅助化疗方式,治疗效果比较好,不仅具有比较高的治愈率,还能够有效的降低不良反应的发生率,可有效提高患者的生存率。
Objective: To analyze the effect of neoadjuvant chemotherapy in gastric cancer. Methods: From September 2013 to August 2014, Wulong County People’s Hospital admitted 60 cases of gastric cancer patients were divided into observation group and control group, 30 cases in each group, the two groups were treated with different treatments, control Group adopted the treatment of simple surgical treatment, observation group adopted the treatment method for the treatment of georgia capsules combined with oxaliplatin (SOX) adjuvant chemotherapy new program, after a period of treatment of the treatment effect of the two groups were analyzed. Results: The cure rate of the control group was significantly lower than that of the observation group (63.33%), and the incidence of adverse reactions in the observation group was 53.33% compared with that of the control group (46.67%). There was no significant difference (P <0.05). Conclusion: The introduction of neoadjuvant chemotherapy in gastric cancer treatment, the treatment effect is better, not only has a high cure rate, but also can effectively reduce the incidence of adverse reactions, which can effectively improve the survival rate of patients.